Two French Biotechs are fighting in court…for nothing

25/09/2015 - 3 minutes

We are all familiar with stories of lawsuits in the tech sector (e.g. remember the Apple and Samsung debacle?) but it’s less well known for Biotechs to butt heads. Nonetheless, the French-Danish Biotech oncology company Onxeo, and Eurofins (a huge 19K employee group which deals in clinical services) fought it out in Paris’ commerce court: to absolutely no end. Both companies were deemed ‘guilty’ and made an example of, by being ordered to pay an equal sum to one another in damages…

imagesThe background: Back in 2005, Onxeo developed a HIV resistance test in collaboration with INSERM and Institut Pasteur. The company then licensed its intellectual property and commercial rights to Eurofins for US distribution. In October 2008, an American subsidiary of Eurofins then sued Onxeo by claiming the asset value was “compromised” and that rights to a third party were hidden…

This third party is ABL (Advanced Biological Laboratories), an American contract research and manufacturing organization based in Rockville,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member